Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Use this ITRM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ITRM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ITRM SEC filings page. Lician reads the product cache first so this HTML stays unique to Iterum Therapeutics PLC even when a live quote feed is slow.
Latest cached year on this hub. Full ITRM income, balance, and cash tables.